Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has issued several clarifications and enforcement actions, including a retraction of a public alert on Deleject needles, blacklisting of Onifam Laboratories, and guidance on handling manufacturer investigation reports for medical devices. These updates signal a focus on regulatory integrity and compliance in the pharmaceutical and medical device sectors, with implications for SMBs in healthcare, food safety, and export.
Pharmaceuticals
Medical Devices
Food Safety
Healthcare
Export
Regulatory Clarification on Deleject Disposable Needle Public Alert No. 042/2026
NAFDAC
NAFDAC clarified that the public alert on Deleject Disposable Needle was uploaded in error and the matter was resolved after review.
SMBs in medical device distribution should verify NAFDAC alerts and maintain communication with the agency to avoid acting on erroneous information.
2026 World Breastfeeding Week Capacity Building Event for Healthcare Professionals
NAFDAC
NAFDAC held a capacity building event for healthcare professionals to promote breastfeeding, emphasizing food safety and nutrition.
SMBs in food and nutrition sectors should align with breastfeeding promotion initiatives and ensure compliance with nutrition labeling standards.
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC celebrated World Breastfeeding Week, reinforcing its commitment to maternal and child nutrition.
SMBs in baby food and nutrition products should expect increased scrutiny on product claims and quality.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC provided guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs to ensure patient safety.
SMBs manufacturing or importing medical devices must establish robust procedures for investigating and reporting quality issues to NAFDAC.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklisted Onifam Laboratories Ltd for regulatory misrepresentation and improper use of approvals, barring them from pharmaceutical activities.
SMBs in pharmaceutical distribution should ensure their suppliers are compliant to avoid association with blacklisted entities.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON is using an electronic platform to facilitate international trade, streamlining export processes.
SMBs engaged in export should leverage SON's e-platform for faster certification and compliance.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export, highlighting the process and benefits.
SMBs in aquaculture should consider registering with NEPC to access export opportunities and comply with export regulations.
Increased regulatory enforcement and blacklisting for non-compliance in pharmaceuticals.
Emphasis on proper handling of medical device quality issues.
Promotion of breastfeeding and nutrition may affect food product marketing.
Digital platforms for trade facilitation are being adopted by regulatory bodies.
Export opportunities in agriculture and aquaculture are being highlighted.
1
Review and update quality management systems for medical devices to align with NAFDAC MIR guidance.
2
Verify the compliance status of all pharmaceutical suppliers and partners.
3
Monitor NAFDAC alerts and clarifications regularly to avoid acting on erroneous information.
4
Engage with NAFDAC for capacity building and training on regulatory compliance.
5
Explore SON's e-platform for export certification to streamline trade processes.
6
Consider registering fish farms with NEPC to expand export market access.